GUFIC BIOSCIENCES LTD. SHARE PRICE [LIVE]

BSE: INE742B01025   NSE: GUFICBIO   SECTOR: Pharma

OPEN YOUR FREE DEMAT ACCOUNT AND START TRADING SEAMLESSLY
Already an existing customer? - Login Now!
NSE
201.95
Change:
BSE
202.50
Change:
NSE
BSE Click here to view BSE data
Loading, Please wait...
Error in Fetching Data, Please retry later.
No data available.
Open:
High:
Low:
MKT Cap:
52-wk High:
52-wk Low:
Prev close:
P/E:
Div yield:

Fundamental analysis

Quality
Valuation
0 250 500 750 1 000
Financial trend

What is not working for the company?

What is working for the company?

Stock
Sector
Sensex
Name Mar 21 Dec 20

Similar Stocks

Return Calculator

This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.

If I had made LUMPSUM investment of ₹ 1,00,000

in GUFIC BIOSCIENCES LTD.

Months ago

My investment would be worth ₹ 1,41,900 with a Gain of 41.90 %

GUFICBIO News

Frequently Asked Questions

What is the Share price of GUFIC BIOSCIENCES LTD. (GUFICBIO)?

GUFIC BIOSCIENCES LTD. (GUFICBIO) share price as of August 18, 2022, on NSE is Rs 201.95 (NSE) and Rs 202.50 (BSE) on BSE.

Can I buy GUFIC BIOSCIENCES LTD. (GUFICBIO) shares?

Yes, You can buy GUFIC BIOSCIENCES LTD. (GUFICBIO) shares by opening a Demat account with Angel One.

How do I buy GUFIC BIOSCIENCES LTD. (GUFICBIO) from Angel One?

GUFIC BIOSCIENCES LTD. (GUFICBIO) share can be brought through the following modes:
  1. Direct investment: You can buy GUFIC BIOSCIENCES LTD. (GUFICBIO) shares by opening a Demat account with Angel One.
  2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to GUFIC BIOSCIENCES LTD. (GUFICBIO) shares.

In which sector do GUFIC BIOSCIENCES LTD. (GUFICBIO) belong?

GUFIC BIOSCIENCES LTD. (GUFICBIO) belongs to Pharma.

About GUFICBIO

Today's live share price for GUFIC BIOSCIENCES LTD. is NSE: ₹ 201.95, BSE: ₹ 202.50 with a current market capitalization of .

Gufic Biosciences (GBL) is a result of a reverse merger of itself with Central Finance. The promoters of GBL took over Central Finance at Rs 40-42 per share and then got GBL listed on BSE. The Choksi and Gandhi family, the promoters of GBL, have a long-standing presence in the pharma industry. In 1960, the family set up a joint venture company called Lyka Labs. In 1976, they decided to part ways and the Choksi family took over the manufacturing facility and the Gufic group of companies was born. Initially known as Gujarat Fine Chemicals, the first foray of the Gufic group was in the manufacture of various bulk drugs. The company later entered the formulation market. Currently, the overall profile of GBL comprises ethical products, herbal products, consumer products and bulk drugs that are sold in the domestic and the international markets. Over the past several years, the company have a known reputation of creating brands that have vaulted to leadership positions in the category in which they have been marketed. To mention a few names: Shapers (sanitary napkins), Onergy, and Stretch nil. In the year 2000, the company issued Bonus Equity Shares in proportion of five Equity shares for every two Equity shares held. Gufic has divested brands in the ethical pharma business in a seller's market. The company plan to invest further in R&D activities and aggressively enter the herbal product and consumer product segments, where it foresee a huge potential. While benefiting from the rich, traditional knowledge base in India, it would like to operate from an area of strength in the herbal products segment.

Read more